ZYMEWORKS INC (US)(ZYME),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ZYME ZYMEWORKS INC (US)

Trading 05-21 10:11:35 EDT

24.83

-0.01

-0.04%

High25.25	Low24.37	Vol50.19K
Open24.44	D1 Closing24.84	Amplitude3.53%
Mkt Cap1.81B	Tradable Cap1.72B	Total Shares73.02M
T/O1.24M	T/O Rate0.07%	Tradable Shares69.37M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ZYME","market":"US","secType":"STK","nameCN":"ZYMEWORKS INC (US)","latestPrice":24.83,"timestamp":1779372692986,"preClose":24.84,"halted":0,"volume":50193,"delay":0,"changeRate":-0.0004025764895330742,"floatShares":69374100,"shares":73023061,"eps":-1.365952,"marketStatus":"Trading","change":-0.01,"latestTime":"05-21 10:11:35 EDT","open":24.44,"high":25.2475,"low":24.37,"amount":1244992.1912999998,"amplitude":0.035326,"askPrice":24.89,"askSize":17,"bidPrice":24.84,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-1.365952,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1779393600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1493352000000,"exchange":"NASDAQ","adjPreClose":24.84,"preHourTrading":{"tag":"盘前","latestPrice":24.3,"preClose":24.84,"latestTime":"08:59 EDT","volume":231,"amount":5697.070302,"timestamp":1779368361974,"change":-0.54,"changeRate":-0.021739,"amplitude":0.048712},"postHourTrading":{"tag":"盘后","latestPrice":24.84,"preClose":24.84,"latestTime":"18:48 EDT","volume":1475,"amount":36654.08,"timestamp":1779317323420,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.750067,"impliedVol":0.6625,"impliedVolPercentile":0.5259},"requestUrl":"/m/hq/s/ZYME/tweets","defaultTab":"tweets","newsList":[{"id":"2635058931","title":"Zymeworks files Form 3 for EVP, General Counsel Paul R. Schneider","url":"https://stock-news.laohu8.com/highlight/detail?id=2635058931","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635058931?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:59","pubTimestamp":1778878762,"startTime":"0","endTime":"0","summary":"Zymeworks filed Form 3 naming Paul R. Schneider as EVP, general counsel.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zymeworks Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL4PggT1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635724620","title":"Zymeworks authorizes share repurchase program of up to $125M","url":"https://stock-news.laohu8.com/highlight/detail?id=2635724620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635724620?lang=en_us&edition=fundamental","pubTime":"2026-05-15 06:14","pubTimestamp":1778796863,"startTime":"0","endTime":"0","summary":"Zymeworks (ZYME) announced that its board of directors has authorized a share repurchase program under which the company may repurchase up to $125M...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-authorizes-share-repurchase-program-of-up-to-125m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-authorizes-share-repurchase-program-of-up-to-125m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635728025","title":"Zymeworks Announces Share Repurchase Program of up to $125 Million of Its Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2635728025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635728025?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:05","pubTimestamp":1778789110,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nFWN41R153:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635020020","title":"Zymeworks management to join Stifel Virtual Targeted Oncology Forum fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2635020020","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635020020?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:00","pubTimestamp":1778666418,"startTime":"0","endTime":"0","summary":"Zymeworks management scheduled to join investor conferences focused on oncology, starting May 20 with a virtual fireside chat at 9:00 a.m. ET.Virtual fireside chat set for May 27 at 4:30 p.m. ET at TD Cowen 7th Annual Oncology Innovation Summit.Jefferies Global Healthcare Conference appearance slated for June 3, including a fireside chat at 8:45 a.m. ET in New York.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDLc7QGrS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NDAQ","IE00BN0W2W23.USD","ZYME","BK4585","SG9999014039.USD","BK4139","IE00BGHQF748.EUR","LU2210149790.SGD","BK4127","SG9999014005.SGD","BK4112","SF","LU0314104364.USD","LU2210150020.SGD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","SG9999014013.SGD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","SG9999014021.USD","LU2095319765.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634404164","title":"Citi Reaffirms Their Buy Rating on Zymeworks (ZYME)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634404164","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634404164?lang=en_us&edition=fundamental","pubTime":"2026-05-10 21:43","pubTimestamp":1778420616,"startTime":"0","endTime":"0","summary":"In a report released on May 8, Yigal Nochomovitz from Citi reiterated a Buy rating on Zymeworks, with a price target of $35.00. The company’s share...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-reaffirms-their-buy-rating-on-zymeworks-zyme-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-reaffirms-their-buy-rating-on-zymeworks-zyme-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634697104","title":"Zymeworks Down Over 9%, on Pace for Largest Percent Decrease Since December 2022 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2634697104","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634697104?lang=en_us&edition=fundamental","pubTime":"2026-05-09 03:07","pubTimestamp":1778267220,"startTime":"0","endTime":"0","summary":"Zymeworks Inc.  is currently at $24.03, down $2.57 or 9.66%. --Would be lowest close since March 24, 2026, when it closed at $23.60. --On pace for largest percent decrease since Dec. 12, 2022, when it fell 10.58%. --Currently down two consecutive days; down 12.97% over this period. --Down 9.70% this week; worst weekly performance since the week ending Jan. 9, 2026, when it fell 12.96%. --Down 57.7% from its all-time closing high of $56.81 on Jan. 8, 2021. --Up 112.56% from 52 weeks ago , when it closed at $11.31. --Down 15.86% from its 52-week closing high of $28.56 on April 27, 2026. --Up 114.17% from its 52-week closing low of $11.22 on May 27, 2025. --Traded as low as $23.39; lowest intraday level since March 24, 2026, when it hit $23.23. --Down 12.07% at today's intraday low; largest intraday percent decrease since Aug. 11, 2023, when it fell as much as 14.81%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633453229","title":"Zymeworks (ZYME) Gets a Buy from Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2633453229","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633453229?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:40","pubTimestamp":1778240431,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Eva Fortea Verdejo maintained a Buy rating on Zymeworks today and set a price target of $34.00. Fortea Verdejo covers the Healt...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/zymeworks-zyme-gets-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/zymeworks-zyme-gets-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1035773651.USD","IE0002270589.USD","LU1267930490.SGD","LU0128525689.USD","BK4504","BK4207","IE000M9KFDE8.USD","LU0787776722.HKD","LU1074936037.SGD","LU1267930227.SGD","LU0971096721.USD","LU0048573561.USD","PGF","ZYME","LU2361044949.HKD","LU0708994859.HKD","LU2461242641.AUD","BK4139","LU0310800379.SGD","LU1363072403.SGD","IE00B19Z3581.USD","LU0310800965.SGD","LU0128525929.USD","LU0130517989.USD","BK4582","LU0106831901.USD","LU0640476718.USD","LU0868494617.USD","LU0130102774.USD","LU0029864427.USD","LU0683600562.USD","LU1668664300.SGD","LU0980610538.SGD","LU2361044865.SGD","LU1814569148.SGD","LU0648001328.SGD","LU0149725797.USD","LU1506573853.SGD","LU0211328371.USD","LU0314106906.USD","LU0417517546.SGD","LU0070302665.USD","LU0052756011.USD","LU1201861249.SGD","BK4585","LU0267386448.USD","LU0208291251.USD","LU0742534661.SGD","IE00B7SZLL34.SGD","LU0175139822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633453260","title":"Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Thermo Fisher (TMO) and Claritev (CTEV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633453260","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633453260?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:40","pubTimestamp":1778240417,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zymeworks (ZYME), Thermo Fisher (TMO) and Claritev (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-thermo-fisher-tmo-and-claritev-ctev-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-thermo-fisher-tmo-and-claritev-ctev-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0208291251.USD","BK4167","LU2720916845.USD","BK4139","LU0070302665.USD","LU0345770993.USD","BK4533","BK4548","LU2125909759.SGD","LU1791710400.SGD","LU2211814178.USD","XBI","BK4137","LU1923622291.USD","LU1153585028.USD","LABU","LU2125909593.SGD","LU2092937221.SGD","LU1061106388.HKD","LU2764262908.HKD","LU2360108059.USD","TMO","LU2764263039.SGD","BK4535","LU0266013472.USD","LU2125909916.SGD","LU1057294990.SGD","LU0029874061.USD","LU2112291526.USD","LU0114720955.EUR","ZYME","CTEV","LU2764263203.CNY","XLV","LU0096362180.USD","LU2468319806.SGD","LU0528227936.USD","IE0034235188.USD","LU1633808545.USD","LU1291159041.SGD","HCSG","LU0316494557.USD","LU2125910336.SGD","IE00B4R5TH58.HKD","LU2543165471.USD","BK4121","LU2298321311.HKD","IE00B1BXHZ80.USD","BK4581","IE00B19Z8W00.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633510587","title":"Zymeworks Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633510587","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633510587?lang=en_us&edition=fundamental","pubTime":"2026-05-08 06:43","pubTimestamp":1778193791,"startTime":"0","endTime":"0","summary":"Zymeworks Inc reports results for the quarter ended March 31 - Earnings SummaryZymeworks Inc ZYME.OQ reported a quarterly adjusted loss of 59 cents per share for the quarter ended March 31, lower than","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL8N41K3L7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633417288","title":"Canada's Zymeworks Q1 revenue misses estimates on absence of prior milestone payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2633417288","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633417288?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:36","pubTimestamp":1778186164,"startTime":"0","endTime":"0","summary":"Canada's Zymeworks Q1 revenue misses estimates on absence of prior milestone paymentsOverviewCanada biotech firm's Q1 revenue and EPS missed analyst expectationsRevenue fell sharply yr/yr due to absen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL1N41K1QF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633745741","title":"Zymeworks Q1 EPS $(0.59) Down From $(0.30) YoY, Sales $2.408M Down From $27.110M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2633745741","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633745741?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:28","pubTimestamp":1778185707,"startTime":"0","endTime":"0","summary":"Zymeworks (NASDAQ:ZYME) reported quarterly losses of $(0.59) per share. This is a 96.67 percent decrease over losses of $(0.30) per share from the same period last year.  The company reported $2.408 million in sales this","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52391267/zymeworks-q1-eps-0-59-down-from-0-30-yoy-sales-2-408m-down-from-27-110m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Zymeworks Q1 EPS $(0.59) Down From $(0.30) YoY, Sales $2.408M Down From $27.110M YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633780789","title":"Zymeworks Inc  expected to post a loss of 19 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633780789","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633780789?lang=en_us&edition=fundamental","pubTime":"2026-05-06 06:47","pubTimestamp":1778021224,"startTime":"0","endTime":"0","summary":"Zymeworks Inc  expected to post a loss of19cents a share - Earnings Preview Zymeworks Inc ZYME.OQ ZYME.O is expected to  show a fall in quarterly revenue when it reports  results on May 7 for the peri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL8N41I3TF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118884204","title":"Earning Preview: ZYMEWORKS INC (US) revenue is expected to decrease by 21.26%, institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1118884204","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118884204?lang=en_us&edition=fundamental","pubTime":"2026-04-30 21:19","pubTimestamp":1777555193,"startTime":"0","endTime":"0","summary":"Abstract Zymeworks Inc. will release its quarterly results on May 7, 2026 Post Market, with consensus pointing to lower revenue but improved earnings metrics as investors weigh regulatory and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Earning Preview: ZYMEWORKS INC (US) revenue is expected to decrease by 21.26%, institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630319727","title":"April 2026's Top 3 Stocks That May Be Trading Below Estimated Fair Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2630319727","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630319727?lang=en_us&edition=fundamental","pubTime":"2026-04-28 01:08","pubTimestamp":1777309715,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has remained flat, yet it has experienced a significant 30% increase over the past year with earnings projected to grow by 16% annually. In this environment, identifying stocks that may be trading below their estimated fair value can present opportunities for investors seeking potential long-term gains.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zyme/zymeworks/news/april-2026s-top-3-stocks-that-may-be-trading-below-estimated","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zyme/zymeworks/news/april-2026s-top-3-stocks-that-may-be-trading-below-estimated","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE0009354923.USD","BK4097","BHST","ALDX","ALNY","LU0889565916.HKD","LU1878469433.USD","GKOS","ASIC","BK4183","LU2065731478.USD","BUSE","BK4548","BK4585","LU0320765992.SGD","OBK","BK4588","FRME","FBK","BK4139","LU0882574055.USD","ZYME","LU0114720955.EUR","ALLT","GLNG","LU0109394709.USD","BK4144","BK4211","CCB","BK4107","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629835592","title":"Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Zymeworks (ZYME) and Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629835592","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629835592?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:21","pubTimestamp":1776943291,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sanofi (SNYNF), Zymeworks (ZYME) and Definium Therap...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sanofi-othersnynf-zymeworks-zyme-and-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sanofi-othersnynf-zymeworks-zyme-and-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0128526141.USD","BK4007","HCSG","BK4137","BK4588","XLV","SNYNF","BK4139","XBI","DFTX","LABU","ZYME","LU0029874061.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629045756","title":"Zymeworks (ZYME) Gets a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2629045756","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629045756?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:00","pubTimestamp":1776859218,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Stephen Willey maintained a Buy rating on Zymeworks today and set a price target of $47.00. Willey covers the Healthcare se...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/zymeworks-zyme-gets-a-buy-from-stifel-nicolaus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/zymeworks-zyme-gets-a-buy-from-stifel-nicolaus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZYME","XLV","BK4585","LABU","BK4581","XBI","SF","BK4139","BK4588","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628479369","title":"A Look At Zymeworks (ZYME) Valuation As AACR 2026 ADC Data Draws Investor Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2628479369","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628479369?lang=en_us&edition=fundamental","pubTime":"2026-04-20 01:07","pubTimestamp":1776618435,"startTime":"0","endTime":"0","summary":"Zymeworks (ZYME) has put its antibody drug conjugate pipeline in the spotlight, announcing six new preclinical data posters and an upcoming Phase 1 ZW191 oral presentation at the AACR Annual Meeting 2026.\nSee our latest analysis for Zymeworks.\nThe recent AACR pipeline update and new executive appointments come after a strong run in the stock, with a 30 day share price return of 19.21% and a 1 year total shareholder return of 141.11%. However, the 5 year total shareholder return of a 1.94%...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zyme/zymeworks/news/a-look-at-zymeworks-zyme-valuation-as-aacr-2026-adc-data-dra","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zyme/zymeworks/news/a-look-at-zymeworks-zyme-valuation-as-aacr-2026-adc-data-dra","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4231","BK4080","ZYME","BK4139","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628878987","title":"Zymeworks to present Phase 1 ZW191 dose-escalation data at AACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2628878987","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628878987?lang=en_us&edition=fundamental","pubTime":"2026-04-18 03:00","pubTimestamp":1776452436,"startTime":"0","endTime":"0","summary":"Zymeworks flagged updated results from Part 1 dose escalation of Phase 1 ZWI-ZW191-101 trial of ZW191 in advanced solid tumors for oral presentation at AACR on April 21, 2026.Early study readout is positioned to inform dose selection and next-step development for ZW191, an FRα-targeted antibody-drug conjugate.Separately, six AACR posters already outline new preclinical findings across Zymeworks’ antibody-drug conjugate pipeline, including tumor-selective delivery claims for a pan-RAS inhibitor ADC platform.Preclinical updates highlight broad anti-tumor activity across solid tumor models with tolerability described as supportive of continued development.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL81fdLY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014005.SGD","BK4588","ZYME","BK4139","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","SG9999014013.SGD","BK4112","IE00BN0W2W23.USD","BK4585","NDAQ","IE00BKPKM429.USD","SG9999014021.USD","LU2095319765.USD","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626444110","title":"Zymeworks files Form 3 for EVP, Chief Business Officer Scott Platshon","url":"https://stock-news.laohu8.com/highlight/detail?id=2626444110","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626444110?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:05","pubTimestamp":1775851546,"startTime":"0","endTime":"0","summary":"Zymeworks Form 3 showed EVP, Chief Business Officer Scott Platshon held stock options for 167,000 shares at USD 22.99.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zymeworks Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 10, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL2fQRRC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626183716","title":"Zymeworks appoints new Head of R&D and Chief Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2626183716","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626183716?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:11","pubTimestamp":1775729465,"startTime":"0","endTime":"0","summary":"Zymeworks (ZYME) announced the full-time appointments of Adam Schayowitz and Scott Platshon as of April 9, from their previously interim roles. Sch...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-appoints-new-head-of-rd-and-chief-business-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-appoints-new-head-of-rd-and-chief-business-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zymeworks.com","stockEarnings":[{"period":"1week","weight":0.011},{"period":"1month","weight":-0.1081},{"period":"3month","weight":0.0652},{"period":"6month","weight":0.0341},{"period":"1year","weight":0.9984},{"period":"ytd","weight":-0.0566}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":0.0459},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.2503},{"period":"ytd","weight":0.087}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.015488},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.056871},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.020874},{"month":4,"riseRate":0.666667,"avgChangeRate":0.045958},{"month":5,"riseRate":0.3,"avgChangeRate":0.006318},{"month":6,"riseRate":0.555556,"avgChangeRate":-0.046141},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.030946},{"month":8,"riseRate":0.888889,"avgChangeRate":0.104131},{"month":9,"riseRate":0.444444,"avgChangeRate":0.038592},{"month":10,"riseRate":0.666667,"avgChangeRate":0.043198},{"month":11,"riseRate":0.777778,"avgChangeRate":0.135367},{"month":12,"riseRate":0.555556,"avgChangeRate":0.004939}],"exchange":"NASDAQ","name":"ZYMEWORKS INC (US)","nameEN":"ZYMEWORKS INC (US)"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ZYMEWORKS INC (US)(ZYME),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ZYMEWORKS INC (US)(ZYME) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ZYMEWORKS INC (US),ZYME,ZYMEWORKS INC (US)股票,ZYMEWORKS INC (US)股票老虎,ZYMEWORKS INC (US)股票老虎国际,ZYMEWORKS INC (US)行情,ZYMEWORKS INC (US)股票行情,ZYMEWORKS INC (US)股价,ZYMEWORKS INC (US)股市,ZYMEWORKS INC (US)股票价格,ZYMEWORKS INC (US)股票交易,ZYMEWORKS INC (US)股票购买,ZYMEWORKS INC (US)股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ZYMEWORKS INC (US)(ZYME),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ZYMEWORKS INC (US)(ZYME) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction